Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A, -- Ignore unavailable to you. Want to Upgrade?

To: Jibacoa who wrote (2934)	6/15/2010 12:58:57 PM
From: Jibacoa	Read Replies (1) \| Respond to of 3722

IPCI is up for 3rd day on a roll. trading above the resistance at the $3 level.<g> Volume remains moderate, but trying to get to its ADV bigcharts.marketwatch.com IPCI announced yesterday that is has filed an ANDA with the FDA for a generic of Protonix. Sales of pantoprazole sodium delayed-release tablets in the U.S. were approximately $1.8 billion in 2009. This is the 4th ANDA product candidate that IPCI has from its 15 product pipeline. There is no ACTAY, but the stock is still trading above its Apr30 H of $3.09 and it seems that it could get back to test the March 12 H at $5.05 <g> bigcharts.marketwatch.com Of course, IPCI has plenty of room to run upstairs.<G> Back in early 2000 it traded at an adjusted price above $1000 <g> bigcharts.marketwatch.com Bernard